This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Institute of Oriental Medicine. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Youngah Kim: Innovator in Peripheral Neuropathy Treatment
Introduction
Youngah Kim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of peripheral neuropathy. His innovative work focuses on utilizing natural extracts to alleviate the side effects of cancer treatments.
Latest Patents
Youngah Kim holds a patent for a composition aimed at the prevention, alleviation, or treatment of peripheral neuropathy. This composition comprises Lithospermi Radix extract as an effective component. The patent highlights the extract's ability to prevent and treat peripheral neuropathy induced by anti-cancer agents, such as chemotherapy. The method involves administering the composition to individuals in need, showcasing its potential to relieve symptoms without causing cytotoxicity in normal cells.
Career Highlights
Youngah Kim is affiliated with the Korea Institute of Oriental Medicine, where he conducts research and develops innovative solutions for health challenges. His work emphasizes the importance of natural remedies in modern medicine, particularly in enhancing the quality of life for cancer patients.
Collaborations
Youngah Kim collaborates with esteemed colleagues, including No Soo Kim and Jong-Shik Park. Their combined expertise contributes to advancing research in the field of peripheral neuropathy and related treatments.
Conclusion
Youngah Kim's contributions to the treatment of peripheral neuropathy through natural extracts represent a significant advancement in medical innovation. His work not only addresses a critical health issue but also highlights the potential of traditional remedies in contemporary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
